157 related articles for article (PubMed ID: 110586)
21. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
Steen VM; Holmsen H
Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
[TBL] [Abstract][Full Text] [Related]
22. ADP-induced inhibition of von Willebrand factor-mediated platelet agglutination.
Grant RA; Zucker MB; McPherson J
Am J Physiol; 1976 May; 230(5):1406-10. PubMed ID: 818909
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP.
Bushfield M; McNicol A; MacIntyre DE
Biochem J; 1985 Nov; 232(1):267-71. PubMed ID: 3002327
[TBL] [Abstract][Full Text] [Related]
24. Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin.
Ware JA; Johnson PC; Smith M; Salzman EW
J Clin Invest; 1986 Mar; 77(3):878-86. PubMed ID: 3081576
[TBL] [Abstract][Full Text] [Related]
25. Effects of N-acetylglucosamine and platelet inhibitors on the synergistic interaction of platelets and aggregating agents in the presence of wheat germ agglutinin.
Tandon NN; Ordinas A; Jamieson GA
Biochim Biophys Acta; 1982 Nov; 719(2):388-95. PubMed ID: 6817815
[TBL] [Abstract][Full Text] [Related]
26. Metabolic aspects of the secretion of stored compounds from blood platelets. V. Effect of ionophore A23187 on washed platelets.
Mürer EH; Davenport K; Rausch MA; Day HJ
Biochim Biophys Acta; 1976 Nov; 451(1):1-19. PubMed ID: 795462
[TBL] [Abstract][Full Text] [Related]
27. Aggregation response of human platelets stored at 22 C as platelet-rich plasma.
Moroff G; Chang CH
Transfusion; 1979; 19(6):704-18. PubMed ID: 42998
[TBL] [Abstract][Full Text] [Related]
28. Extracellular ATP inhibits agonist-induced mobilization of internal calcium in human platelets.
Soslau G; McKenzie RJ; Brodsky I; Devlin TM
Biochim Biophys Acta; 1995 Jul; 1268(1):73-80. PubMed ID: 7626665
[TBL] [Abstract][Full Text] [Related]
29. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
Williams KA; Murphy W; Haslam RJ
Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
[TBL] [Abstract][Full Text] [Related]
30. The influence of prostaglandin G2 on platelet ultrastructure and platelet secretion.
Gerrard JM; Townsend D; Stoddard S; Witkop CJ; White JG
Am J Pathol; 1977 Jan; 86(1):99-116. PubMed ID: 188341
[TBL] [Abstract][Full Text] [Related]
31. Inhibition by ADP of prostaglandin induced accumulation of cyclic AMP in intact human platelets.
Macfarlane DE; Mills DC
J Cyclic Nucleotide Res; 1981; 7(1):1-11. PubMed ID: 6265510
[TBL] [Abstract][Full Text] [Related]
32. Responses to adenosine diphosphate in human platelets loaded with the fluorescent calcium indicator quin2.
Hallam TJ; Rink TJ
J Physiol; 1985 Nov; 368():131-46. PubMed ID: 4078739
[TBL] [Abstract][Full Text] [Related]
33. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
[TBL] [Abstract][Full Text] [Related]
34. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.
Mills DC; Smith JB
Biochem J; 1971 Jan; 121(2):185-96. PubMed ID: 4330088
[TBL] [Abstract][Full Text] [Related]
35. Effects on the buoyant density of rabbit platelets of ADP and agents that increase the concentration of cyclic AMP.
Packham MA; Perry DW; Kinlough-Rathbone RL; Rand ML; Guccione MA; Evans RM; Mustard JF
Blood; 1985 Mar; 65(3):564-70. PubMed ID: 2982440
[TBL] [Abstract][Full Text] [Related]
36. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
[TBL] [Abstract][Full Text] [Related]
37. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
Lam SC; Guccione MA; Packham MA; Mustard JF
Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543
[TBL] [Abstract][Full Text] [Related]
38. The mechanism of adenosine diphosphate induced platelet aggregation: binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E 1 .
Boullin DJ; Green AR; Price KS
J Physiol; 1972 Mar; 221(2):415-26. PubMed ID: 5020984
[TBL] [Abstract][Full Text] [Related]
39. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
[TBL] [Abstract][Full Text] [Related]
40. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
